Literature DB >> 26292694

Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.

James B Wetmore1, Jiannong Liu1, Thy P Do2, Kimberly A Lowe2, Areef Ishani3, Brian D Bradbury2, Geoffrey A Block4, Allan J Collins5.   

Abstract

BACKGROUND: Little is known about changes in parathyroid hormone (PTH), calcium and phosphorous levels after parathyroidectomy in hemodialysis patients. We studied the effects of parathyroidectomy on these biochemical values in a large cohort of patients receiving maintenance hemodialysis.
METHODS: This retrospective cohort study included patients identified in both the United States Renal Data System and the database of a large dialysis organization who underwent parathyroidectomy in 2007-09, were aged ≥ 18 years, had Medicare Parts A and B as primary payer and had received hemodialysis for ≥ 1 year pre-parathyroidectomy. Descriptive statistics were calculated for continuous variables; categorical variables were used to characterize the population and evaluate monthly laboratory and medication use; median values were calculated for laboratory measures.
RESULTS: Among 1402 parathyroidectomy patients, mean age was 48.9 years, 52.4% were males, 58.8% were African American and mean dialysis duration was 7.5 years. Median PTH levels increased over the year before parathyroidectomy from 1039 to 1661 pg/mL and decreased afterward to 98 pg/mL at 1 month; levels remained ≥ 897 pg/mL for 10% of patients. Median calcium levels fell from 9.6 mg/dL before to 7.9 mg/dL 1 month after parathyroidectomy; levels were ≤ 7.1 mg/dL for 25% and remained ≤ 7.2 mg/dL for the lowest 25% at 3 months. Median phosphorous level was 6.8 mg/dL immediately before parathyroidectomy, decreased to 3.8 mg/dL immediately after and reached 5.8 mg/dL at 1 year.
CONCLUSIONS: While PTH levels dropped after parathyroidectomy for most patients, surgery was sometimes ineffective in reducing levels and sometimes led to over-suppression. Hypocalcemia could be profound and long lasting, suggesting the need for prolonged vigilance.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  dialysis; end-stage renal disease; mineral metabolism; parathyroidectomy; secondary hyperparathyroidism

Mesh:

Substances:

Year:  2015        PMID: 26292694     DOI: 10.1093/ndt/gfv291

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Parathyroidectomy: Complex Decisions about a Complex Procedure.

Authors:  James B Wetmore
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-06       Impact factor: 8.237

Review 2.  [Management of secondary hyperparathyroidism-current impact of parathyroidectomy].

Authors:  Emanuel Zitt; Karl Lhotta
Journal:  Wien Med Wochenschr       Date:  2016-02-25

Review 3.  Old and New Drugs for the Management of Bone Disorders in CKD.

Authors:  Hirotaka Komaba; Markus Ketteler; John Cunningham; Masafumi Fukagawa
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

4.  Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis.

Authors:  Qianqian Yuan; Yiqin Liao; Rui Zhou; Jiuyang Liu; Jianing Tang; Gaosong Wu
Journal:  Langenbecks Arch Surg       Date:  2019-08-03       Impact factor: 3.445

5.  Predictors of early postoperative hypocalcemia in patients with secondary hyperparathyroidism undergoing total parathyroidectomy.

Authors:  Wei Gong; Yaqi Lin; Yu Xie; Zilu Meng; Yudong Wang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis.

Authors:  James B Wetmore; Jiannong Liu; Paul J Dluzniewski; Areef Ishani; Geoffrey A Block; Allan J Collins
Journal:  BMC Surg       Date:  2016-11-29       Impact factor: 2.102

7.  The Effect of Parathyroidectomy on Risk of Hip Fracture in Secondary Hyperparathyroidism.

Authors:  Elin Isaksson; Kerstin Ivarsson; Shahriar Akaberi; Andreas Muth; Gunnar Sterner; Prütz Karl-Göran; Naomi Clyne; Martin Almquist
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

Review 8.  Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.

Authors:  Keith E Eidman; James B Wetmore
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-02-05

9.  Use of intraoperative parathyroid hormone measurements during parathyroidectomy to predict postoperative parathyroid hormone levels in patients with renal hyperparathyroidism: meta-analysis.

Authors:  Dirk-Jan van Beek; Stina Fredriksson; Stefanie Haegele; Marco Raffaelli; Philipp Riss; Martin Almquist
Journal:  BJS Open       Date:  2022-01-06

10.  Therapeutic experience of severe and recurrent secondary hyperparathyroidism in a patient on hemodialysis for 18 years: A case report.

Authors:  Mingwen Zhu; Zongming Zhang; Fangcai Lin; Jieping Miao; Pei Wang; Chong Zhang; Hongwei Yu; Hai Deng; Zhuo Liu; Limin Liu; Baijiang Wan; Haiyan Yang; Mengmeng Song; Yue Zhao; Nan Jiang; Zichao Zhang; Zhenya Zhang; Lijie Pan
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.